China NMPA Inspection - Gansu Kangshida Technology Group Co., Ltd. - April 27, 2017

An unannounced inspection report, published on April 27, 2017, by the Chinese regulatory authorities, revealed critical deficiencies at Gansu Kangshida Technology Group Co., Ltd. The inspection focused on the company's adherence to the Good Manufacturing Practice (GMP) for Medical Devices and identified significant non-compliance within its quality management system. Specifically, the findings indicated that the company's operational processes and internal controls fell short of the stringent requirements outlined in the GMP guidelines, which are fundamental for ensuring the safety, quality, and efficacy of medical devices. The report highlights that Gansu Kangshida Technology Group Co., Ltd. failed to meet the relevant standards for manufacturing medical devices, impacting various aspects of its production and quality assurance. Consequently, the Gansu Provincial Food and Drug Administration has officially ordered the company to undertake immediate and thorough rectification of all identified shortcomings. This mandate requires the implementation of comprehensive corrective actions within a specified period to bring the company's quality management system and manufacturing practices into full alignment with the regulatory framework. This enforcement action emphasizes the NMPA's commitment to upholding high standards in medical device manufacturing and protecting public health through strict adherence to established regulatory practices.